Naloxone Firms Commit To Boost Capacities In White House Opioid Overdose Epidemic Meeting

Emergent BioSolutions, Harm Reduction Therapetuics, Hikma, Teva and other drug manufacturers commit to increased supply of naloxone and nalmefene in meeting with ]White House Office of National Drug Control.

Picture of Narcan spray
• Source: Shutterstock

Manufacturers of opioid overdose reversal drugs, including several generics firms, intend produce an additional 25m doses of their products in the US following a meeting with the White House Office of National Drug Control Policy.

More from Rx-to-OTC Switch

More from Health